Reliable health monitoring via voice, anywhere, anytime.


Symptonic is a research initiative at Aalto University, supported by Business Finland's Research to Business funding, dedicated to developing advanced technology for reliable detection and monitoring of various disorders through speech signal analysis.This non-invasive, cost-effective, and scalable approach aims to transform global healthcare by enabling early detection and monitoring of diseases.

Making health insights as simple as speaking


Your voice holds powerful clues about your health. Our platform analyses subtle changes in speech to deliver objective, real-time insights – supporting patients and clinicians in detecting and managing a range of conditions with greater ease and accuracy.

Vision: Speech as a gateway to proactive care


We’re building a speech-based diagnostic platform to enable earlier detection, continuous monitoring, and more personalised care for a wide range of health conditions, including:Neurological disorders – such as Parkinson’s and Alzheimer’sCardiovascular conditions – including heart failureMental health challenges – like depression and anxietyRespiratory diseases – including asthma and COVID-19By turning everyday speech into clinically meaningful data, we aim to make health monitoring seamless, scalable, and accessible – using the device already in your hand.

Join us in shaping the future of healthcare


We are actively seeking collaborators for pilot projects to validate and enhance our technology.If you are a healthcare provider, research institution, or technology company interested in pioneering speech-based diagnostics, we invite you to connect with us.

IN COLLABORATION WITH

Contact


Mikko Petäjä
Business champion
[email protected]
+358 50 522 7335
Saska Tirronen
Technical champion
[email protected]
+358 45 117 1283


© 2025 Symptonic. All rights reserved.Symptonic is a research project currently in development at Aalto University. Our technology is not yet available for commercial or medical use. Through Business Finland's Research to Business funding, we are preparing to explore potential future commercialization opportunities for our research findings.